Dr. Copeland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3651 Ridge Mill Dr
Hilliard, OH 43026Phone+1 614-293-3873Fax+1 614-293-3078- Is this information wrong?
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1977 - 1979
- University of Western OntarioClass of 1973
- University of WaterlooB.S., 1966 - 1969
Certifications & Licensure
- OH State Medical License 1988 - 2025
- FL State Medical License 2015 - 2020
- TX State Medical License 1979 - 1991
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- President GOG Foundation
- America's Top Doctors Castle Connolly, 2002-2018
- America's Top Doctors for Cancer Castle Connolly, 2005-2017
- Join now to see all
Clinical Trials
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass Start of enrollment: 2005 Oct 01
- Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer Start of enrollment: 2005 Nov 01
Publications & Presentations
PubMed
- Changes in prospectively collected patient-reported outcomes among women with incident endometrial cancer.Sinnott, J., Torkashvand, E., Meade, C., Hall, B., Skolnick, R., Hebert, C., Felix, A., Salani, R., Vetter, M., Bixel, K., Cohn, D., Cosgrove, C., Copeland, L.> ;Journal of Cancer Survivorship. 2024 Jan 24
- Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on ...Monica D Levine, Heather Wang, Bhargavi Sriram, Ambar Khan, Leigha Senter, Eric M McLaughlin, Kristin L Bixel, Laura M Chambers, David E Cohn, Larry J Copeland, Casey ...> ;Gynecologic Oncology. 2024 Mar 1
- Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study.Chan, J., Tian, C., Kesterson, J., Lin, K., Darcy, K., Richardson, M., Kapp, D., Monk, B., McNally, L., Landrum, L., Copeland, L., Walker, J., Wenham, R., Phippen, N.,...> ;Gynecologic Oncology. 2024 Feb 1
- Join now to see all
Journal Articles
- Radiation-associated Angiosarcoma Mimicking Fallopian Tube High-grade Serous Carcinoma in a Woman With De Novo Li-Fraumeni SyndromeSarah M. Crafton, Leigha Senter-Jamieson, James L. Chen, Larry J. Copeland, M.D., and Adrian A. Suarez, Int J Gynecol Pathol, 1/1/2018
- Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?Smith B, McCann GA, Phillips G, Backes FJ, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ, Salani R, Gynecol Oncol, 1/1/2017
- Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based careSenter, L, O�Malley DM, Backes FJ, Copeland LJ, Fowler JM, Salani R, Cohn, DE, Gynecol Oncol, 1/1/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Adherence to a standard algorithm results in high negative predictive value of sentinel lymph node assessment using indocyanine green (ICG) and isosulfan blue (ISB) dy...DM O�Malley, R. Salani, DE Cohn, LJ Copeland, JM Fowler, Proc Soc Gynecol Oncol, 1/1/2015
- Setting the bar: compliance with ovarian cancer quality indicators at a national Cancer Institute (NCI) � designated Comprehensive Cancer Center (CCC)AC ElNaggar, S. Nekkanti, DM O�Malley, EM Hade, LJ Copeland, JM Fowler, R Salani FJ Backes, DE Cohn, Proc Soc Gynecol Oncol, 1/1/2015
- The use of NCCN guideline therapy in the first line/adjuvant setting in patients with ovarian cancer from 6 NCCN institutionsJ. Niland, MA Bookman, RA Burger, M Cristea,J Griggs, GM Mantia-Smaldone, LA Meyer, CC L Lun, A Wright DE Cohn, Proc Soc Gynecol Oncol, 1/1/2015
- Join now to see all
Other
- Sarah Crafton, Leiga Senter, James Chen, Larry Copeland, Adrian SuarezSarah Crafton, Leiga Senter, James Chen, Larry Copeland, Adrian Suarez
1/1/2018 - Oncology: Treatment and Management, 6th Edition (Course Consultant: Copeland LJ, Saul PB)CMR Institute, Inc.
1/1/2014 - Severe Pegfilgrastim-Induced Bone Pain completely Alleviated with Loratadine: A Case ReportRomeo C, Copeland L, Li Q
1/1/2014 - Join now to see all
Press Mentions
- ENGOT-en6-NSGO/GOG-3031/RUBY Trial Results: The New Standard of Care in advanced/recurrent Endometrial CancerMarch 27th, 2023
- The GOG Foundation, Inc., the Society of Gynecologic Oncology, and the Foundation for Women’s Cancer Announce Synergistic Partnership to Advance the Missions of All Three OrganizationsNovember 1st, 2022
- Additional Taxane Maintenance Therapy Does Not Successfully Improve Overall Survival for Women with Advanced Ovarian, Peritoneal, and Tubal CancersJune 28th, 2022
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
Hospital Affiliations
- Ohio State University Wexner Medical CenterColumbus, Ohio
- The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: